Abbott Laboratories (ABT) Tops Q3 EPS by 1c; Narrows FY11 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq hit record highs as Treasury yields stall, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $99.05 -1.05%
EPS Growth %: +9.2%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
TMQ, OMH, AEHR, More
EPS Growth %: +9.2%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
TMQ, OMH, AEHR, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q3 EPS of $1.18, $0.01 better than the analyst estimate of $1.17. Revenue for the quarter came in at $9.82 billion versus the consensus estimate of $9.65 billion.
Abbott Laboratories sees FY2011 EPS of $4.64-$4.66, versus prior guidance of $4.58-$4.68 and the consensus of $4.64.
Abbott Laboratories sees FY2011 EPS of $4.64-$4.66, versus prior guidance of $4.58-$4.68 and the consensus of $4.64.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lamb Weston (LW) Tops Q1 EPS by 15c ; Offers Guidance
- AbbVie updates 2026 earnings guidance with Q3 R&D charges
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
